» Articles » PMID: 18201576

Viruses Associated with Human Cancer

Overview
Specialties Biochemistry
Biophysics
Date 2008 Jan 19
PMID 18201576
Citations 162
Authors
Affiliations
Soon will be listed here.
Abstract

It is estimated that viral infections contribute to 15-20% of all human cancers. As obligatory intracellular parasites, viruses encode proteins that reprogram host cellular signaling pathways that control proliferation, differentiation, cell death, genomic integrity, and recognition by the immune system. These cellular processes are governed by complex and redundant regulatory networks and are surveyed by sentinel mechanisms that ensure that aberrant cells are removed from the proliferative pool. Given that the genome size of a virus is highly restricted to ensure packaging within an infectious structure, viruses must target cellular regulatory nodes with limited redundancy and need to inactivate surveillance mechanisms that would normally recognize and extinguish such abnormal cells. In many cases, key proteins in these same regulatory networks are subject to mutation in non-virally associated diseases and cancers. Oncogenic viruses have thus served as important experimental models to identify and molecularly investigate such cellular networks. These include the discovery of oncogenes and tumor suppressors, identification of regulatory networks that are critical for maintenance of genomic integrity, and processes that govern immune surveillance.

Citing Articles

Human Cytomegalovirus Infection and Breast Cancer: A Literature Review of Clinical and Experimental Data.

Blanco R, Munoz J Biology (Basel). 2025; 14(2).

PMID: 40001942 PMC: 11851556. DOI: 10.3390/biology14020174.


Equivocating and Deliberating on the Probability of COVID-19 Infection Serving as a Risk Factor for Lung Cancer and Common Molecular Pathways Serving as a Link.

Amara A, Trabelsi S, Hai A, Zaidi S, Siddiqui F, Alsaeed S Pathogens. 2025; 13(12.

PMID: 39770330 PMC: 11728627. DOI: 10.3390/pathogens13121070.


Risk assessment and triage strategy of cervical cancer primary screening on HPV integration status: 5-year follow-up of a prospective cohort study.

Tian X, Weng D, Chen Y, Wang Y, Li X, Wang X J Natl Cancer Cent. 2024; 4(4):311-317.

PMID: 39735440 PMC: 11674434. DOI: 10.1016/j.jncc.2024.08.001.


Cancer treatment approaches within the frame of hyperthermia, drug delivery systems, and biosensors: concepts and future potentials.

Sayed Z, Hieba E, Batakoushy H, Rashdan H, Ismail E, Elkatlawy S RSC Adv. 2024; 14(53):39297-39324.

PMID: 39670162 PMC: 11635600. DOI: 10.1039/d4ra06992g.


Avian Models for Human Carcinogenesis-Recent Findings from Molecular and Clinical Research.

Niebora J, Data K, Domagala D, Jozkowiak M, Barrett S, Norizadeh Abbariki T Cells. 2024; 13(21.

PMID: 39513904 PMC: 11544849. DOI: 10.3390/cells13211797.


References
1.
Jones D, Thompson D, Munger K . Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. Virology. 1998; 239(1):97-107. DOI: 10.1006/viro.1997.8851. View

2.
Uhlik M, Good L, Xiao G, Harhaj E, Zandi E, Karin M . NF-kappaB-inducing kinase and IkappaB kinase participate in human T-cell leukemia virus I Tax-mediated NF-kappaB activation. J Biol Chem. 1998; 273(33):21132-6. DOI: 10.1074/jbc.273.33.21132. View

3.
Wei Y, Etiemble J, Fourel G, Vitvitski-Trepo L, Buendia M . Hepadna virus integration generates virus-cell cotranscripts carrying 3' truncated X genes in human and woodchuck liver tumors. J Med Virol. 1995; 45(1):82-90. DOI: 10.1002/jmv.1890450116. View

4.
Funk W, Pak D, Karas R, Wright W, Shay J . A transcriptionally active DNA-binding site for human p53 protein complexes. Mol Cell Biol. 1992; 12(6):2866-71. PMC: 364481. DOI: 10.1128/mcb.12.6.2866-2871.1992. View

5.
Brechot C . Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology. 2004; 127(5 Suppl 1):S56-61. DOI: 10.1053/j.gastro.2004.09.016. View